These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25499024)

  • 1. Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix® drug coated balloon.
    Escárcega RO; Waksman R
    Cardiovasc Revasc Med; 2014; 15(8):402-7. PubMed ID: 25499024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.
    Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ
    Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia.
    Case BC; Torguson R; Zhang C; Waksman R
    Cardiovasc Revasc Med; 2021 Dec; 33():55-61. PubMed ID: 34246613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the 2011 food and drug administration's circulatory system devices panel of the medical devices advisory committee meeting on the Zilver® PTX® drug-eluting peripheral stent.
    Dvir D; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2012; 13(5):281-5. PubMed ID: 22898055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries.
    Sixt S; Carpio Cancino OG; Treszl A; Beschorner U; Macharzina R; Rastan A; Krankenberg H; Neumann FJ; Zeller T
    J Vasc Surg; 2013 Sep; 58(3):682-6. PubMed ID: 23755977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-related balloons and stents for the treatment of peripheral artery disease: Insights from the Food and Drug Administration 2019 Circulatory System Devices Panel Meeting on late mortality.
    Dan K; Shlofmitz E; Khalid N; Hideo-Kajita A; Wermers JP; Torguson R; Kolm P; Garcia-Garcia HM; Waksman R
    Am Heart J; 2020 Apr; 222():112-120. PubMed ID: 32028137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lutonix® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease.
    Schorn I; Malinoff H; Anderson S; Lecy C; Wang J; Giorgianni J; Papandreou G
    Adv Drug Deliv Rev; 2017 Mar; 112():78-87. PubMed ID: 28559093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
    Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
    Kolodgie FD; Pacheco E; Yahagi K; Mori H; Ladich E; Virmani R
    J Vasc Interv Radiol; 2016 Nov; 27(11):1676-1685.e2. PubMed ID: 27641674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents for PAD: what does (all) the data tell us?
    Phillips J
    J Cardiovasc Surg (Torino); 2019 Aug; 60(4):433-438. PubMed ID: 31058479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug coated balloon angioplasty in the treatment of peripheral artery disease.
    Colleran R; Harada Y; Cassese S; Byrne RA
    Expert Rev Med Devices; 2016 Jun; 13(6):569-82. PubMed ID: 27152654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S
    J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN transcatheter heart valve for high-risk aortic stenosis patients.
    Barbash IM; Dvir D; Waksman R
    Am Heart J; 2013 May; 165(5):710-5. PubMed ID: 23622907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-coated balloons and their place in treating peripheral arterial disease.
    Schnorr B; Albrecht T
    Expert Rev Med Devices; 2013 Jan; 10(1):105-14. PubMed ID: 23278227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N; Schneider H
    J Endovasc Ther; 2013 Dec; 20(6):819-25. PubMed ID: 24325699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials.
    Ohki T; Yokoi H; Kichikawa K; Kimura T; Snyder SA; Ragheb AO; O'Leary EE; Jaff MR; Ansel GM; Dake MD
    J Endovasc Ther; 2014 Oct; 21(5):644-53. PubMed ID: 25290792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral applications of drug-coated balloons: past, present and future.
    Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the 2011 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting on the CardioMEMS Champion Heart Failure Monitoring System.
    Loh JP; Barbash IM; Waksman R
    J Am Coll Cardiol; 2013 Apr; 61(15):1571-6. PubMed ID: 23352783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.